North America Pulmonary Devices Market

Market Introduction

Pulmonary or respiratory devices are mostly used for the patients suffering from the respiratory diseases such as chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with the respiratory tract.

North America Pulmonary Devices Strategic Insights

Strategic insights for the North America Pulmonary Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Pulmonary Devices Report Scope

North America Pulmonary Devices Regional Insights

The geographic scope of the North America Pulmonary Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The North America pulmonary devices market is expected to reach US$ 16,637.44 million by 2027 from US$ 7,581.04 million in 2019. The market is anticipated to grow at a CAGR of 10.3% during 2019–2027. The rising number of COVID-19 cases and increasing prevalence of respiratory diseases are the major factors expected to boost the growth of the pulmonary devices market in North America. However, the market is likely to get impacted by the risk factor such as unfavorable reimbursement scenario associated with respiratory devices during the forecast period.

Key Market Segments

In terms of type, the therapeutic devices segment accounted for the largest share of the North America pulmonary devices market in 2019. In terms of application, chronic obstructive pulmonary disease (COPD) segment accounted for the largest share of the North America pulmonary devices market in 2019. In terms of end user, the hospitals segment accounted for the largest share of the North America pulmonary devices market in 2019.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the North America pulmonary devices market report are the World Health Organization (WHO), US Department of Health and Human Services, Centers of Disease Control and Prevention (CDC), and others.

Reasons to buy report

• It provides understanding of the North America, pulmonary devices market landscape and identifies pulmonary devices market segments that are most likely to guarantee a strong return.
• It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America pulmonary devices market.
• It helps efficiently plan merger and acquisition, and partnership deals in the pulmonary devices market by identifying market segments with the most promising probable sales
• It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of pulmonary devices market performance of various segments pertaining to the North America pulmonary devices market.
• It provides pulmonary devices market revenue forecast of the market based on various segments for the period from 2019 to 2027.

NORTH AMERICA PULMONARY DEVICES MARKET SEGMENTATION

By Type

• Therapeutic Devices
• Consumables and Accessories
• Diagnostic Devices
• Monitoring Devices

By Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Others

By End User

• Hospitals
• Home Care Settings
• Ambulatory Care Centers

By Country

• US
• Canada
• Mexico

Company Profiles

• ResMed
• Masimo
• Invacare Corporation
• Koninklijke Philips N.V.
• Getinge AB